{"database": "openregs", "table": "documents", "rows": [["FDA-2016-P-4587-0004", "FDA", "FDA-2016-P-4587", "Exhibit B Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am. J. Respir. Crit. Care Med. 1996:153;1985-87 re Citizen Petition from Mallinckrodt Pharmaceuticals", "Supporting & Related Material", "Background Material", "2016-12-28T05:00:00Z", 2016, 12, null, null, "2016-12-28T21:51:25Z", null, 0, 0, "090000648243b8fa"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2016-P-4587-0004"], "units": {}, "query_ms": 0.3576489398255944, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}